Literature DB >> 11746358

Expression of arginase isozymes in mouse brain.

H Yu1, R K Iyer, R M Kern, W I Rodriguez, W W Grody, S D Cederbaum.   

Abstract

The two forms of arginase (AI and AII) in man, identical in enzymatic function, are encoded in separate genes and are expressed differentially in various tissues. AI is expressed predominantly in the liver cytosol and is thought to function primarily to detoxify ammonia as part of the urea cycle. AII, in contrast, is predominantly mitochondrial, is more widely expressed, and is thought to function primarily to produce ornithine. Ornithine is a precursor in the synthesis of proline, glutamate, and polyamines. This study was undertaken to explore the cellular and regional distribution of AI and AII expression in brain using in situ hybridization and immunohistochemistry. AI and AII were detected only in neurons and not in glial cells. AI presented stronger expression than AII, but AII was generally coexpressed with AI in most cells studied. Expression was particularly high in the cerebral cortex, cerebellum, pons, medulla, and spinal cord neurons. Glutamic acid decarboxylase 65 and glutamic acid decarboxylase 67, postulated to be related to the risk of glutamate excitotoxic and/or gamma-aminobutyric acid inhibitoxic injury, were similarly ubiquitous in their expression and generally paralleled arginase expression patterns, especially in cerebral cortex, hippocampus, cerebellum, pons, medulla, and spinal cord. This study showed that AI is expressed in the mouse brain, and more strongly than AII, and sheds light on the anatomic basis for the arginine-->ornithine-->glutamate-->GABA pathway. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746358     DOI: 10.1002/jnr.1233

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

1.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 2.  Targeting innate immunity for neurodegenerative disorders of the central nervous system.

Authors:  Katrin I Andreasson; Adam D Bachstetter; Marco Colonna; Florent Ginhoux; Clive Holmes; Bruce Lamb; Gary Landreth; Daniel C Lee; Donovan Low; Marina A Lynch; Alon Monsonego; M Kerry O'Banion; Milos Pekny; Till Puschmann; Niva Russek-Blum; Leslie A Sandusky; Maj-Linda B Selenica; Kazuyuki Takata; Jessica Teeling; Terrence Town; Linda J Van Eldik
Journal:  J Neurochem       Date:  2016-09       Impact factor: 5.372

3.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

Review 4.  Role of Astrocytes in Manganese Neurotoxicity Revisited.

Authors:  Tao Ke; Marta Sidoryk-Wegrzynowicz; Edward Pajarillo; Asha Rizor; Félix Alexandre Antunes Soares; Eunsook Lee; Michael Aschner
Journal:  Neurochem Res       Date:  2019-09-30       Impact factor: 3.996

5.  Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.

Authors:  Christopher S Hackett; David A Quigley; Robyn A Wong; Justin Chen; Christine Cheng; Young K Song; Jun S Wei; Ludmila Pawlikowska; Yun Bao; David D Goldenberg; Kim Nguyen; W Clay Gustafson; Sundari K Rallapalli; Yoon-Jae Cho; James M Cook; Serguei Kozlov; Jian-Hua Mao; Terry Van Dyke; Pui-Yan Kwok; Javed Khan; Allan Balmain; QiWen Fan; William A Weiss
Journal:  Cell Rep       Date:  2014-10-23       Impact factor: 9.423

6.  Arginase overexpression in neurons and its effect on traumatic brain injury.

Authors:  Simran Madan; Bettina Kron; Zixue Jin; George Al Shamy; Philippe M Campeau; Qin Sun; Shan Chen; Leela Cherian; Yuqing Chen; Elda Munivez; Ming-Ming Jiang; Claudia Robertson; Clay Goodman; Rajiv R Ratan; Brendan Lee
Journal:  Mol Genet Metab       Date:  2018-07-25       Impact factor: 4.797

7.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

8.  Expression of immune-regulatory genes, arginase-2 and inducible nitric oxide synthase (iNOS), in two rainbow trout (Oncorhynchus mykiss) strains following exposure to Myxobolus cerebralis.

Authors:  Vanessa I C Severin; Hatem Soliman; Mansour El-Matbouli
Journal:  Parasitol Res       Date:  2009-11-06       Impact factor: 2.289

9.  Mouse model for human arginase deficiency.

Authors:  Ramaswamy K Iyer; Paul K Yoo; Rita M Kern; Nora Rozengurt; Rosemarie Tsoa; William E O'Brien; Hong Yu; Wayne W Grody; Stephen D Cederbaum
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 10.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.